Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report
The Journal of Dermatology · 2026-11 · 53 (11)
DOI: 10.1111/1346-8138.70480 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 25.08.2026. Verfasst von Manoj Bhagwat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York, USA.
ORCID-Profile: Manoj Bhagwat, Joshua Mijares, Alexandra Flamm, Vignesh Ramachandran
Zitieren
APA
Bhagwat, M., Mijares, J., Flamm, A., & Ramachandran, V. (2026). Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report. The Journal of Dermatology, 53(11). https://doi.org/10.1111/1346-8138.70480
Vancouver
Bhagwat M, Mijares J, Flamm A, Ramachandran V. Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report. The Journal of Dermatology. 2026;53(11). doi:10.1111/1346-8138.70480
BibTeX
@article{Bhagwat2026,
author = {Bhagwat, Manoj and Mijares, Joshua and Flamm, Alexandra and Ramachandran, Vignesh},
title = {Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report},
journal = {The Journal of Dermatology},
year = {2026},
volume = {53},
number = {11},
doi = {10.1111/1346-8138.70480}
}
EUVIMED